Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium

Human Pathology

Volumn 46, Issue 7, 2015, Pages 957-962

  Iwamoto, Masami ^a   Nakatani, Yukio ^a   Fugo, Kazunori ^a   Kishimoto, Takashi ^a   Kiyokawa, Takako ^b  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Clear cell carcinoma; Endometrial carcinoma; Napsin A; Ovarian carcinoma; PAX8

Indexed keywords

CA 125 ANTIGEN; NAPSIN A; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR PAX8; TUMOR MARKER; UNCLASSIFIED DRUG; ASPARTIC PROTEINASE; MEMBRANE PROTEIN; MUC16 PROTEIN, HUMAN; NAPSA PROTEIN, HUMAN; NUCLEAR PROTEIN; PAIRED BOX TRANSCRIPTION FACTOR; PAX8 PROTEIN, HUMAN; THYROID NUCLEAR FACTOR 1; TRANSCRIPTION FACTOR;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; OVARY CARCINOMA; PROTEIN EXPRESSION; THYROID PARAFOLLICULAR CELL; CARCINOMA; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; ENDOMETRIUM TUMOR; ENZYMOLOGY; OVARY TUMOR; PATHOLOGY; PREDICTIVE VALUE;

ASPARTIC ACID ENDOPEPTIDASES; BIOMARKERS, TUMOR; CA-125 ANTIGEN; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PAIRED BOX TRANSCRIPTION FACTORS; PREDICTIVE VALUE OF TESTS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84931006101     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2015.03.008     Document Type: Article

References (35)

1. M.J. Kim, H.C. Shin, K.C. Shin, and J.Y. Ro Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens Ann Diagn Pathol 17 2013 85 90
2. T. Hirano, G. Auer, and M. Maeda Human tissue distribution of TA02, which is homologous with a new type of aspartic proteinase, napsin A Jpn J Cancer Res 91 2000 1015 1021
3. T. Hirano, Y. Gong, and K. Yoshida Usefulness of TA02 (napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma Lung Cancer 41 2003 155 162
4. L.M. Stoll, M.W. Johnson, E. Gabrielson, F. Askin, D.P. Clark, and Q.K. Li The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas Cancer Cytopathol 118 2010 441 449
5. S. Mukhopadhyay, and A.L. Katzenstein Comparison of monoclonal napsin A, polyclonal napsin A, and TTF-1 for determining lung origin in metastatic adenocarcinomas Am J Clin Pathol 138 2012 703 711
6. B.M. Turner, P.T. Cagle, I.M. Sainz, J. Fukuoka, S.S. Shen, and J. Jagirdar Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray Arch Pathol Lab Med 136 2012 163 171
7. M. Kadivar, and B. Boozari Applications and limitations of immunohistochemical expression of "Napsin-A" in distinguishing lung adenocarcinoma from adenocarcinomas of other organs Appl Immunohistochem Mol Morphol 21 2013 191 195
8. J.A. Bishop, R. Sharma, and P.B. Illei Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma Hum Pathol 41 2010 20 25
9. D. Lim, P. Ip, A. Cheung, T. Kiyokawa, and E. Oliva An immunohistochemical comparison of ovarian and uterine endometrioid carcinoma, endometrioid carcinoma with clear cell change and clear cell carcinoma 2014 USCAP Poster [#1211]
10. P.L. Kandalaft, A.M. Gown, and C. Isacson The lung-restricted marker napsin a is highly expressed in clear cell carcinomas of the ovary Am J Clin Pathol 142 2014 830 836
11. M.Y. Kim, H. Go, and J. Koh Napsin A is a useful marker for metastatic adenocarcinomas of pulmonary origin Histopathology 65 2014 195 206
12. Y. Yamashita, T. Nagasaka, and A. Naiki-Ito Napsin A is a specific marker for ovarian clear cell adenocarcinoma Mod Pathol 28 2015 111 117
13. I. Skirnisdottir, K. Bjersand, H. Akerud, and T. Seidal Napsin A as a marker of clear cell ovarian carcinoma BMC Cancer 13 2013 524 535
14. O. Fadare, M.M. Desouki, and K. Gwin Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility Am J Surg Pathol 38 2014 189 196
15. H.S. Bae, H. Kim, S.Y. Kwon, K.R. Kim, J.Y. Song, and I. Kim Should endometrial clear cell carcinoma be classified as type II endometrial carcinoma? Int J Gynecol Pathol 34 2014 74 84
16. L.N. Hoang, M.K. McConechy, and B. Meng Targeted mutation analysis of endometrial clear cell carcinoma Histopathology 66 2015 664 674
17. B.J. Holmes, B.M. Ronnett, J.D. Seidman, and A. Yemelyanova Napsin A: a sensitive immunohistochemical marker for uterine clear cell carcinoma 2014 USCAP poster [#1181]
18. R.J. Kurman, M.L. Carcangiu, C.S. Herrington, and R.H. Young WHO classification of tumours of female reproductive organs 4th ed. 2014 IARC Press Lyon
19. M. Kobel, S.E. Kalloger, and J. Carrick A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary Am J Surg Pathol 33 2009 14 21
20. O. Fadare, W. Zheng, and M.A. Crispens Morphologic and other clinicopathologic features of endometrial clear cell carcinoma: a comprehensive analysis of 50 rigorously classified cases Am J Cancer Res 3 2013 70 95
21. J. Ye, J.J. Findeis-Hosey, and Q. Yang Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung Appl Immunohistochem Mol Morphol 19 2011 313 317
22. S.K. Lau, D.J. Luthringer, and R.N. Eisen Thyroid transcription factor-1: a review Appl Immunohistochem Mol Morphol 10 2002 97 102
23. J. Jagirdar Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma to the lung Arch Pathol Lab Med 132 2008 384 396
24. A. Tan, D. Etit, U. Bayol, D. Altinel, and S. Tan Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma Ann Diagn Pathol 15 2011 108 116
25. E. Compérat, F. Zhang, and C. Perrotin Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin Mod Pathol 18 2005 1371 1376
26. K. Siami, W.G. McCluggage, and N.G. Ordonez Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas Am J Surg Pathol 31 2007 1759 1763
27. L.A. Kubba, W.G. McCluggage, and J. Liu Thyroid transcription factor-1 expression in ovarian epithelial neoplasms Mod Pathol 21 2008 485 490
28. P.J. Zhang, H.G. Gao, T.L. Pasha, L. Litzky, and V.A. Livolsi TTF-1 expression in ovarian and uterine epithelial neoplasia and its potential significance, an immunohistochemical assessment with multiple monoclonal antibodies and different secondary detection systems Int J Gynecol Pathol 28 2009 10 18
29. J.E. Larsen, T. Cascone, D.E. Gerber, J.V. Heymach, and J.D. Minna Targeted therapies for lung cancer: clinical experience and novel agents Cancer J 17 2011 512 527
30. N.G. Ordonez Value of PAX 8 immunostaining in tumor diagnosis: a review and update Adv Anat Pathol 19 2012 140 151
31. A. Ozcan, N. Liles, D. Coffey, S.S. Shen, and L.D. Truong PAX2 and PAX8 expression in primary and metastatic mullerian epithelial tumors: a comprehensive comparison Am J Surg Pathol 35 2011 1837 1847
32. T.S. Loy, J.T. Quesenberry, and S.C. Sharp Distribution of CA 125 in adenocarcinomas. An immunohistochemical study of 481 cases Am J Clin Pathol 98 1992 175 179
33. M.M. Streppel, A. Vincent, and R. Mukherjee Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon Hum Pathol 43 2012 1755 1763
34. D.G. Rosen, L. Wang, and J.N. Atkinson Potential markers that complement expression of CA125 in epithelial ovarian cancer Gynecol Oncol 99 2005 267 277
35. S. Nur, L. Chuang, and G. Ramaswamy Immunohistochemical characterization of cancer antigen in uterine cancers Int J Gynecol Cancer 16 2006 1903 1910